Jordan E Axelrad

50PUBLICATIONS
100CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Aug 06, 2026
Reutilization of biologics for postoperative Crohn's disease recurrence prevention is effective.

|May 27, 2026
Communicating Risk and Safety of Inflammatory Bowel Disease Therapies.

|May 19, 2026
MAIT cell enrichment in Lynch syndrome is associated with immune surveillance and colorectal cancer risk.

|Feb 06, 2026
Type I and III interferons synergize with TNF to promote virally-triggered damage to the intestinal epithelium.

Lucie Bernard-Raichon, Jessica A Neil, Kayla Kim

|Oct 22, 2025
Treatment-Free Outcomes Following Surgery for IBD: A Nationwide Cohort Study.

Adam S Faye, Jordan Axelrad, Jiangwei Sun

|Oct 15, 2025
Mild Endoscopic Disease Activity Is Associated With Adverse Outcomes Among Older Adults With Inflammatory Bowel Disease.

Catherine Z Tang, Olivia R Delau, Seymour Katz

Pageof 9

Frequent Collaborators

7 joint publications

Jonas F Ludvigsson

5 joint publications

Ola Olén

5 joint publications

Adam S Faye

5 joint publications

Ken H Cadwell